课题基金 / 基金详情

Spatial control of Ca2+ signals in lymphocytes

Spatial control of Ca2+ signals in lymphocytes
淋巴细胞中 Ca2 信号的空间控制
批准号:
7502928
负责人:
MAKIO IWASHIMA
金额:
$10.84万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-01 至 2008-12-31

项目摘要

项目成果

MAKIO IWASHIMA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Lymphocyte activation consists of multiple intracellular signaling processes. This complexity allows lymphocytes to regulate their function in various ways so that their differentiation and activation are properly carried out. Impairment in this complex system could lead to malfunctioning of the immune system, such as autoimmunity, allergy, and immunodeficiency. Nuclear factor of activated T-cells (NF-AT) is regarded as one of the most important transcription factors that controls lymphocyte activation. NF-AT is activated by Ca2+/calmodulin-dependent phosphatase calcineurin (CN). The interaction between NF-AT and CN is inhibited by FK506 and Cyclosporin A, which are broadly utilized for suppression of the immune responses. Recently, several cellular and viral proteins were also determined as the inhibitors of CN/NF-AT interaction. In the preliminary study, we identify a protein Repslthat binds the lymphoid specific Src family kinase Lck and plays a critical role in NF-AT activation in lymphocytes. Repsl is highly expressed in thymocytes and other lymphoid organs. Gene knockout of Repsl in a chicken B-cell line DT-40 resulted in abolishment of NF-AT activation due to lack of NF-AT dephosphorylation. NF-AT activation was not restored even when cells were stimulated by pharmacological agents that bypass proximal signaling events. Further, transgenic mice expressing a mutant form of Repsl in T cells showed significantly reduced IL-2 production by mature T cells. Together, the data indicates that Repsl plays an essential role in lymphocyte activation. In this study, we will analyze the detailed mechanism of Repsl function in vitro and its biological significance in vivo.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1002/eji.202149633
发表时间: 2022-07
期刊: EUROPEAN JOURNAL OF IMMUNOLOGY
影响因子: 5.4
作者: [Cunha, Christina, Koike, Toru, Seki, Yoichi, Yamamoto, Mutsumi, Iwashima, Makio]
通讯作者: Iwashima, Makio
DOI: 10.4049/jimmunol.0900753
发表时间: 2010-01-01
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者: [Singh N, Yamamoto M, Takami M, Seki Y, Takezaki M, Mellor AL, Iwashima M]
通讯作者: Iwashima M
Function of Siglec 5 in T cell activation.
  • 批准号:
    10373619
  • 项目类别:
  • 资助金额:
    $18.45万
  • 财政年份:
    2022
  • 负责人:
    MAKIO IWASHIMA
  • 依托单位:
Function of Siglec 5 in T cell activation.
  • 批准号:
    10665549
  • 项目类别:
  • 资助金额:
    $22.3万
  • 财政年份:
    2022
  • 负责人:
    MAKIO IWASHIMA
  • 依托单位:
Immune checkpoint modulation by bacterial metabolites.
  • 批准号:
    10246854
  • 项目类别:
  • 资助金额:
    $22.25万
  • 财政年份:
    2020
  • 负责人:
    MAKIO IWASHIMA
  • 依托单位:
Immunomodulatory properties of umbilical cord blood
  • 批准号:
    8606811
  • 项目类别:
  • 资助金额:
    $21.76万
  • 财政年份:
    2013
  • 负责人:
    MAKIO IWASHIMA
  • 依托单位:
海外基金